Sijibio and Korean Society of Obesity and Cosmetic Treatment Sign MOU to Advance Obesity Cosmetic Treatments and Petit Procedures

Jigeonhyun, President of the Korean Society of Obesity and Aesthetic Treatment (Director of Yonsei Dongan Clinic, left), and Yuhyeonseung, CEO of SJ Bio, are signing a business agreement.

[Asia Economy Reporter Lee Gwan-joo] CJ Bio, a bio regenerative medicine specialist company, announced on the 7th that it has signed a Memorandum of Understanding (MOU) with the Korean Society of Obesity and Aesthetic Treatment to promote the development of obesity aesthetic treatment and petit procedures.

This agreement was signed to promote the development of the domestic aesthetic market through creative research and in-depth academic exchanges. To this end, they plan to cooperate in ▲participation and lectures at the Korean Society of Obesity and Aesthetic Treatment's spring and autumn academic conferences ▲establishment and operation of liposuction and SVF (Stromal Vascular Fraction) transplantation education programs.

The liposuction and SVF education programs jointly operated by the society and CJ Bio will consist of cadaver workshops and live hands-on sessions designed to deeply convey safe and accurate procedure methods to domestic and international medical professionals. Through theoretical education and practice, the goal is to establish these as leading aesthetic procedure education programs in Korea.

Yoo Hyun-seung, CEO of CJ Bio, said, “The SVF and stem cell fields have been actively researched at CJ Bio for some time, and we are pleased to sign an agreement that can promote the development of the obesity and aesthetic market.”

This content was produced with the assistance of AI translation services.